AMRX logo

Amneal Pharmaceuticals (AMRX)

Profile

Full Name

Amneal Pharmaceuticals, Inc.

Ticker Symbol

AMRX

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

May 7, 2018

Indexes

Not included

Website

http://www.amneal.com

Employees

8300

Key Details

Price

$7.17(-0.55%)

Market cap

$2.22B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.79B(+16.73% YoY)

Annual EPS

-$0.38(+20.83% YoY)

PE ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$7.17
AMRX price is $7.17

30-Day Relative Volume

0.63
AMRX 30-day relative volume is 0.63

Price Performance

Price Most recent change

-0.55%
AMRX price was down -0.55% on Apr 15, 2025

Price YTD change

-9.47%
AMRX price is down -9.47% since January 1st

Price 1-year change

+29.42%
AMRX price is up +29.42% year-on-year

Price 3-year change

+74.03%
AMRX price is up +74.03% over the past 3 years

Price Range

Price All-time high

$24.48
AMRX price is currently -70.71% below its historical high of $24.48

Price 3-year low

$1.24
AMRX price is currently +478.23% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.22B
AMRX market capitalization is $2.22 billion

Market cap 3-year change

+257.77%
AMRX market capitalization is up +257.77% over the past 3 years

Market cap All-time high

$3.09B
AMRX market capitalization is currently -28.01% below its historical high of $3.09 billion

Market cap sector rank

83.88%
AMRX market capitalization is higher than 83.88% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.44%
AMRX shares outstanding is up +0.44% year-on-year

Shares Outstanding 3-Year Change

+105.58%
AMRX shares outstanding is up +105.58% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.89
AMRX beta is 0.89

200-day SMA

$8.13
AMRX price is currently -11.81% below its 200-day simple moving average

50-day SMA

$8.18
AMRX price is currently -12.32% below its 50-day simple moving average

RSI

36.09
AMRX 14-day relative strength index is 36.09

Volume

0.63
AMRX 30-day relative volume is 0.63

ATR

$0.38
AMRX average true range is $0.38

10-day Historical Volatility

61.96%
AMRX 10-day historical volatility is 61.96%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.79B
AMRX annual revenue is $2.79 billion

Revenue Analysts estimate

$3.03B
AMRX annual revenue is currently -7.69% lower than the consensus analysts' forecast

Revenue 1-year change

+16.73%
AMRX annual revenue is up +16.73% year-on-year

Revenue Sector rank

87.91%
AMRX annual revenue is higher than 87.91% of companies in Healthcare sector

EPS

EPS

-$0.38
AMRX annual earnings per share is -$0.38

EPS Analysts estimate

$0.68
AMRX annual earnings per share is currently -155.86% lower than the consensus analysts' forecast

EPS 1-year change

+20.83%
AMRX annual earnings per share is up +20.83% year-on-year

EPS Sector rank

71.88%
AMRX annual earnings per share is higher than 71.88% of companies in Healthcare sector

Profit

Gross profit

$1.02B
AMRX annual gross profit is $1.02 billion

Gross margin

36.52%
AMRX annual gross profit margin is 36.52%

Operating profit

$296.76M
AMRX annual operating income is $296.76 million

Operating margin

10.62%
AMRX annual operating profit margin is 10.62%

Net income

-$116.89M
AMRX annual net profit is -$116.89 million

Net margin

-4.18%
AMRX annual net profit margin is -4.18%

Expenses

Total expenses

$2.50B
AMRX annual total expenses is $2.50 billion

Operating expenses

$723.67M
AMRX annual total operating expenses is $723.67 million

Cost of goods sold

$1.77B
AMRX annual cost of goods sold is $1.77 billion

Selling, general & administrative expenses

$476.44M
AMRX annual SGA is $476.44 million

Depreciation and amortization

$236.19M
AMRX annual depreciation & amortization is $236.19 million

Interest expense

$258.60M
AMRX annual interest expense is $258.60 million

Income tax

$18.86M
AMRX annual income tax is $18.86 million

EBIT & EBITDA

EBIT

$203.58M
AMRX annual earnings before interest & taxes is $203.58 million

EBITDA

$439.77M
AMRX annual EBITDA is $439.77 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$3.50B
AMRX annual total assets is $3.50 billion

Non current assets

$1.91B
AMRX annual long term assets is $1.91 billion

Current assets

$1.59B
AMRX annual total current assets is $1.59 billion

Cash and cash equivalents

$110.55M
AMRX annual cash & cash equivalents is $110.55 million

Accounts receivable

$775.73M
AMRX annual accounts receivable is $775.73 million

Inventory

$612.45M
AMRX annual inventory is $612.45 million

Liabilities

Total liabilities

$3.61B
AMRX annual total liabilities is $3.61 billion

Long term liabilities

$2.48B
AMRX annual total long term liabilities is $2.48 billion

Current liabilities

$1.13B
AMRX annual total current liabilities is $1.13 billion

Accounts payable

$258.69M
AMRX annual accounts payable is $258.69 million

Debt

Total debt

$2.59B
AMRX annual total debt is $2.59 billion

Total debt 1-year change

-5.72%
AMRX annual total debt is down -5.72% year-on-year

Long term debt

$2.25B
AMRX annual long term debt is $2.25 billion

Short term debt

$340.25M
AMRX annual short term debt is $340.25 million

Equity & Capital

Shareholders equity

-$109.27M
AMRX annual stockholders equity is -$109.27 million

Book value

-$109.27M
AMRX annual book value is -$109.27 million

Retained earnings

-$607.06M
AMRX annual retained earnings is -$607.06 million

Working capital

$458.04M
AMRX annual working capital is $458.04 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$295.10M
AMRX annual cash flow from operations is $295.10 million

Cash from operations 1-year change

-14.61%
AMRX annual cash flow from operations is down -14.61% year-on-year

Cash from investing

-$63.00M
AMRX annual cash flow from investing activities is -$63.00 million

Cash from investing 1-year change

+8.95%
AMRX annual cash flow from investing activities is up +8.95% year-on-year

Cash from financing

-$211.79M
AMRX annual cash flow from financing activities is -$211.79 million

Cash from financing 1-year change

+0.37%
AMRX annual cash flow from financing activities is up +0.37% year-on-year

CAPEX

CAPEX

$74.99M
AMRX annual capital expenditures is $74.99 million

CAPEX 1-year change

+8.38%
AMRX annual capital expenditures is up +8.38% year-on-year

Free Cash Flow

Free cash flow

$220.11M
AMRX annual free cash flow is $220.11 million

Free cash flow 1-year change

-20.36%
AMRX annual free cash flow is down -20.36% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

36.52%
AMRX annual gross profit margin is 36.52%

Operating margin

10.62%
AMRX annual operating profit margin is 10.62%

Net margin

-4.18%
AMRX annual net profit margin is -4.18%

ROA & ROE

ROA

-3.35%
AMRX annual return on assets is -3.35%

ROE

106.97%
AMRX annual return on equity is 106.97%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
AMRX price to earnings ratio value is unknown

PE ratio Sector rank

-
AMRX price to earnings ratio is unknown

PB Ratio

PB ratio

-20.34
AMRX price to book ratio is -20.34

PB ratio Sector rank

1.81%
AMRX price to book ratio is higher than 1.81% of companies in Healthcare sector

PS Ratio

PS ratio

0.80
AMRX price to sales ratio is 0.80

PS ratio Sector rank

24.23%
AMRX price to sales ratio is higher than 24.23% of companies in Healthcare sector

Enterprise value

Enterprise value

$4.71B
AMRX enterprise value is $4.71 billion

Enterprise value Sector rank

87.44%
AMRX enterprise value is higher than 87.44% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

10.70
AMRX EV/EBITDA is 10.70

EV/EBITDA Sector rank

83.04%
AMRX EV/EBITDA is higher than 83.04% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.41
AMRX annual current ratio is 1.41

Quick ratio

0.86
AMRX annual quick ratio is 0.86

Leverage

Debt to equity

-22.75
AMRX annual debt to equity ratio is -22.75

Interest coverage ratio

0.79
AMRX annual interest coverage ratio is 0.79

Risk & Stability

Piotroski F-Score

5
AMRX piotroski f-score is 5

Altman Z-Score

1.27
AMRX altman z-score is 1.27

Analyst ratings

Recent major analysts updates

Mar 3, 25 Barclays
Overweight
Feb 24, 25 JP Morgan
Overweight
Nov 11, 24 Piper Sandler
Overweight
Oct 2, 24 Truist Securities
Buy
Sep 6, 24 JP Morgan
Neutral
Aug 13, 24 Barclays
Overweight
Aug 12, 24 Truist Securities
Buy
May 6, 24 Truist Securities
Buy
May 6, 24 Goldman Sachs
Buy
Mar 21, 24 Piper Sandler
Overweight

Institutional Ownership

Similar stocks

CERT logo
Certara (CERT)
RXRX logo
Recursion Pharmaceuticals (RXRX)
AGL logo
agilon health (AGL)
ACHC logo
Acadia Healthcare (ACHC)
FOLD logo
Amicus Therapeutics (FOLD)
MLTX logo
MoonLake Immunotherapeutics (MLTX)
SEM logo
Select Medical Holdings (SEM)
VCEL logo
Vericel (VCEL)
TWST logo
Twist Bioscience (TWST)
  • What is the ticker symbol for Amneal Pharmaceuticals?
  • Does Amneal Pharmaceuticals pay dividends?
  • What sector is Amneal Pharmaceuticals in?
  • What industry is Amneal Pharmaceuticals in?
  • What country is Amneal Pharmaceuticals based in?
  • When did Amneal Pharmaceuticals go public?
  • Is Amneal Pharmaceuticals in the S&P 500?
  • Is Amneal Pharmaceuticals in the NASDAQ 100?
  • Is Amneal Pharmaceuticals in the Dow Jones?
  • When was Amneal Pharmaceuticals's last earnings report?
  • When does Amneal Pharmaceuticals report earnings?
  • Should I buy Amneal Pharmaceuticals stock now?

What is the ticker symbol for Amneal Pharmaceuticals?

The ticker symbol for Amneal Pharmaceuticals is NYSE:AMRX

Does Amneal Pharmaceuticals pay dividends?

No, Amneal Pharmaceuticals does not pay dividends

What sector is Amneal Pharmaceuticals in?

Amneal Pharmaceuticals is in the Healthcare sector

What industry is Amneal Pharmaceuticals in?

Amneal Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry

What country is Amneal Pharmaceuticals based in?

Amneal Pharmaceuticals is headquartered in United States

When did Amneal Pharmaceuticals go public?

Amneal Pharmaceuticals's initial public offering (IPO) was on May 7, 2018

Is Amneal Pharmaceuticals in the S&P 500?

No, Amneal Pharmaceuticals is not included in the S&P 500 index

Is Amneal Pharmaceuticals in the NASDAQ 100?

No, Amneal Pharmaceuticals is not included in the NASDAQ 100 index

Is Amneal Pharmaceuticals in the Dow Jones?

No, Amneal Pharmaceuticals is not included in the Dow Jones index

When was Amneal Pharmaceuticals's last earnings report?

Amneal Pharmaceuticals's most recent earnings report was on Feb 28, 2025

When does Amneal Pharmaceuticals report earnings?

The next expected earnings date for Amneal Pharmaceuticals is May 2, 2025

Should I buy Amneal Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page